Related Experiment Video
Updated: May 20, 2026

12:55
Purification of Human S100A12 and Its Ion-induced Oligomers for Immune Cell Stimulation
Published on: September 29, 2019
Target binding to S100B reduces dynamic properties and increases Ca(2+)-binding affinity for wild type and EF-hand
Melissa A Liriano1, Kristen M Varney, Nathan T Wright
1Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Journal of Molecular Biology
|July 25, 2012
Summary
Mutations in S100B
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- S100B is a calcium-binding protein involved in various cellular processes.
- Understanding S100B's calcium binding and dynamics is crucial for elucidating its function.
- TRTK-12 is a known target of S100B.
Purpose of the Study:
- To investigate the role of the second EF-hand in S100B's calcium binding and dynamic properties.
- To determine how binding to the target TRTK-12 affects S100B's calcium affinity and dynamics.
Main Methods:
- Site-directed mutagenesis to create EF2-hand mutants of S100B (D61N, D63N, D65N, E72A).
- Isothermal titration calorimetry (ITC) to measure calcium binding affinities.
- Nuclear Magnetic Resonance (NMR) spectroscopy, including relaxation dispersion, to assess protein dynamics.
- X-ray crystallography to determine structural changes upon calcium and TRTK-12 binding.
Main Results:
- EF2-hand mutations significantly reduced calcium binding affinity compared to wild-type S100B in the absence of TRTK-12.
- TRTK-12 binding increased the calcium-binding affinity of both wild-type and mutant S100B proteins.
- NMR studies revealed that TRTK-12 binding reduced protein dynamics (R(ex) and backbone motions).
- X-ray structures did not show altered calcium coordination, suggesting dynamics, not static structure, explain affinity changes.
Conclusions:
- The second EF-hand of S100B is critical for high-affinity calcium binding.
- Target binding by TRTK-12 enhances S100B's calcium-binding affinity through modulation of protein dynamics.
- A model is proposed where altered protein dynamics upon TRTK-12 binding allosterically increase calcium affinity.
Related Concept Videos
The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Catenins
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
